It is possible that abundant exogenous TGF-β may trigger autocrine production of CXCL12 by AML cells and further stimulate CXCL12/CXCR4 signaling, which is diminished by 1D11. The gene discussed is CXCL12; the disease is acute myeloid leukemia.